The present invention relates to the field of anti-tumor technology. The present invention discloses an anti-tumor
prediction system for
dexrazoxane in ESCC, comprising a base, a bracket, a control device, a console, an electrocardiographic induction device, a detection probe, a
magnet, a
radio frequency generator, a data
receiver, a shielding box, and a display screen, wherein the electrocardiographic induction device is connected to the upper part of the console, the
magnetic field is used for a stable and non-changing
magnetic field environment, the
radio frequency generator is used for transmitting a pulse
signal, the data
receiver is used for transmitting the
signal to the control device by
wireless transmission, the prediction result is displayed on the display screen, the
dexrazoxane concentration is changed by controlling the dosage of
chemotherapy drugs, the heart damage is detected by electrocardiogram and magnetic
resonance means, and an effective
dexrazoxane use range can be predicted by combining historical data and experimental data to establish a dexrazoxane use prediction model, which avoids the risk of non-standard use of dexrazoxane failing to achieve
heart protection to a certain extent.